These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9760029)

  • 21. Vasorelaxing effect in rat thoracic aorta caused by laurotetanine isolated from Litsea cubeba Persoon.
    Chen WY; Ko FN; Wu YC; Lu ST; Teng CM
    J Pharm Pharmacol; 1994 May; 46(5):380-2. PubMed ID: 8083812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between structure and vascular activity in a series of benzylisoquinolines.
    Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P
    Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of a causal relationship between the vasodilator effect of papaverine and cyclic AMP production in the dog basilar artery.
    Fujioka M
    Br J Pharmacol; 1984 Sep; 83(1):113-24. PubMed ID: 6091822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papaverine-induced inhibition of electrical and mechanical activity and calcium movements of rat ileal smooth muscle.
    Huddart H; Saad KH
    J Exp Biol; 1980 Jun; 86():99-114. PubMed ID: 7400753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines.
    Chuliá S; Ivorra MD; Lugnier C; Vila E; Noguera MA; D'Ocon P
    Br J Pharmacol; 1994 Dec; 113(4):1377-85. PubMed ID: 7889295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of Li+ on contractile elements of intestinal smooth muscle.
    Hori M; Shimizu K; Nakajyo S; Karaki H; Urakawa N
    Jpn J Pharmacol; 1995 May; 68(1):111-8. PubMed ID: 7494373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic inhibitory effects of atriopeptin II and isoproterenol on contraction of rat aortic smooth muscle: roles of cGMP and cAMP.
    Jang EK; Davidson MM; Crankshaw D; Haslam RJ
    Eur J Pharmacol; 1993 Dec; 250(3):477-81. PubMed ID: 8112409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphosphodiesterase activity and nonspecific smooth muscle relaxation tested on intestinal smooth muscles.
    Inatomi N; Takayanagi I; Takagi K
    Jpn J Pharmacol; 1975 Feb; 25(1):63-9. PubMed ID: 168424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of relaxing action of the antiasthmatic drug, azelastine, in isolated porcine tracheal smooth muscle.
    Sanagi M; Ozaki H; Mitsui M; Karaki H
    Eur J Pharmacol; 1992 Nov; 222(2-3):247-55. PubMed ID: 1333407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle.
    Tanaka T; Ishikawa T; Hagiwara M; Onoda K; Itoh H; Hidaka H
    Pharmacology; 1988; 36(5):313-20. PubMed ID: 2841693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of procaine on contraction and calcium movement in vascular and intestinal smooth muscles.
    Ahn HY; Karaki H
    Br J Pharmacol; 1988 Jul; 94(3):789-96. PubMed ID: 3179612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contractile responses of the guinea pig ileal longitudinal muscle to antispasmodics (author's transl)].
    Kin M; Uruno T; Kubota K
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):851-9. PubMed ID: 202547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of forskolin on myosin phosphorylation-dependent and independent contractions in bovine tracheal smooth muscle.
    Tajimi M; Hori M; Mitsui M; Ozaki H; Karaki H
    J Smooth Muscle Res; 1995 Aug; 31(4):129-42. PubMed ID: 8589501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
    Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
    Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying the vascular and hypotensive actions of the labdane ent-3-acetoxy-labda-8(17),13-dien-15-oic acid.
    Simplicio JA; Pernomian L; Simão MR; Carnio EC; Batalhão ME; Ambrosio SR; Tirapelli CR
    Eur J Pharmacol; 2014 Mar; 726():66-76. PubMed ID: 24463178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.